Skip to main content
SpringerLink
Log in

Dronedarone: Das neue Antiarrhythmikum?

Dronedarone: the new antiarrythmic agent?

  • Originalarbeit
  • Published:
Herzschrittmachertherapie + Elektrophysiologie Aims and scope Submit manuscript

Zusammenfassung

Das Medikament Dronedaron wird als die „Nachfolgesubstanz“ von Amiodaron gehandelt, da ein schnellerer und effektiver Wirkungseintritt bei geringeren Nebenwirkungen zu erwarten ist. Diese Übersichtsarbeit stellt die pharmakologischen Eigenschaften dieses „Multi-Kanal-Blockers“ vor und belegt anhand aktueller Studienergebnisse die erfolgreiche antiarrhythmische Therapie mit Dronedaron bei Patienten mit Vorhofflimmern.

Abstract

Dronedarone is recommended as the successor drug to amiodarone because a faster onset of effects and less side effects are to be expected. This review describes the pharmacological properties of this multi-channel blocker and summarizes the results from recent studies proving successful antiarrhythmic therapy using dronedarone in patients with atrial fibrillation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Chatelain P, Meysmans L, Matteazzi JR et al (1995) Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart. Br J Pharmacol 116:1949–1956

    CAS  PubMed  Google Scholar 

  2. Connolly S (2008) ATHENA: Effect of dronedarone on cardiovascular outcomes and stroke risk in atrial fibrillation. Vortrag auf dem Kongress der European Society of Cardiology, München, 3. September 2008

  3. Davy JM, Herold M, Hoglund C et al. (2008) Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The efficacy and safety of dronedarone for the control of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 156:527 e1–9

    Article  PubMed  Google Scholar 

  4. Doggrell SA, Hancox JC (2004) Dronedarone: an amiodarone analogue. Expert Opin Investig Drugs 13:415–426

    Article  CAS  PubMed  Google Scholar 

  5. Hodeige D, Heyndrickx JP, Chatelain P, Manning A (1995) SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogs. Eur J Pharmacol 279:25–32

    Article  CAS  PubMed  Google Scholar 

  6. Hohnloser SH, Kuck KH, Lilienthal J (2000) Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 356:1789–1794

    Article  CAS  PubMed  Google Scholar 

  7. Hohnloser SH, Crijns HJGM, van Eickels M et al. (2009) Effect of dDronedarone on Cardiovascular Events in Atrial Fibrillation. N Engl J Med 360:668–678

    Article  CAS  PubMed  Google Scholar 

  8. Kathofer S, Thomas D, Karle CA (2005) The novel antiarrhythmic drug dronedarone: comparison with amiodarone. Cardiovasc Drug Rev 23:217–320

    CAS  PubMed  Google Scholar 

  9. Kober L, Torp-Pedersen C, McMurray JJV et al. (2008) Increased Mortality after Dronedarone Therapy for Severe Heart Failure. N Engl J Med 358:2678–2687

    Article  PubMed  Google Scholar 

  10. Lalevee N, Nargeot J, Barrere-Lemaire S et al (2003) Effects of amiodarone and dronedarone on voltage-dependent sodium current in human cardiomyocytes. J Cardiovasc Electrophysiol 14:885–890

    Article  PubMed  Google Scholar 

  11. Naccarelli GV, Wolbrette DL, Khan M et al (2003) Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol 91:15D–26D

    Article  CAS  PubMed  Google Scholar 

  12. Page R, Connolly S, Crijns H (2008) Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation: Insights from the ATHENA trial (Abstract 4097). Vortrag bei American Heart Association Scientific Sessions; 8–12. November 2008; New Orleans, USA

  13. Pritchett EL, Page RL, Connolly SJ (2000) Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response. Azimilide Supraventricular Arrhythmia Program 3 (SVA-3) Investigators. J Am Coll Cardiol 36:794–802

    Article  CAS  PubMed  Google Scholar 

  14. Singh BN, Connolly SJ, Crijns HJ et al (2007) Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 357:987–999

    Article  CAS  PubMed  Google Scholar 

  15. Sun W, Sarma JS, Singh BN (2002) Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone. J Cardiovasc Pharmacol 39:677–84

    Article  CAS  PubMed  Google Scholar 

  16. Torp-Pedersen C, Page R, Connolly S (2008) The effect of dronedarone on hospitalizations in patients with atrial fibrillation. Results from the ATHENA study (Abstract 41019) Vortrag bei American Heart Association 2008 Scientific Sessions; 8.-12. November 2008; New Orleans, USA

  17. Touboul P, Brugada J, Capucci A (2003) Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J 24:1481–1487

    Article  CAS  PubMed  Google Scholar 

  18. Varro A, Takacs J, Nemeth M et al (2001) Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone. Br J Pharmacol 133:625–634

    Article  CAS  PubMed  Google Scholar 

  19. Zareba KM (2006) Dronedarone: a new antiarrhythmic agent. Drugs Today (Barc) 42:75–86

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. II. Medizinische Klinik, Klinikum Coburg, Ketschendorfer Str. 33, 96450, Coburg, Deutschland

    J. Brachmann & A.-M. Sinha

Authors
  1. J. Brachmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A.-M. Sinha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Brachmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brachmann, J., Sinha, AM. Dronedarone: Das neue Antiarrhythmikum?. Herzschr. Elektrophys. 20, 73–75 (2009). https://doi.org/10.1007/s00399-009-0042-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00399-009-0042-9

Schlüsselwörter

Keywords

Search

Navigation